Latest Regulatory Milestones News

Page 13 of 84
Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.
Maxwell Dee
Maxwell Dee
25 Mar 2026
Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.
Ada Torres
Ada Torres
25 Mar 2026
Nickel Industries has secured a significant increase in its 2026 ore sales license and finalized a long-term supply agreement for its Excelsior Nickel Cobalt project, enhancing production certainty and sustainability.
Maxwell Dee
Maxwell Dee
25 Mar 2026
Amplia Therapeutics reports a remarkable 7.8% complete response rate and improved survival in its ACCENT pancreatic cancer trial, positioning narmafotinib as a promising new treatment option.
Ada Torres
Ada Torres
23 Mar 2026
Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.
Claire Turing
Claire Turing
23 Mar 2026
Sentinel Metals has reached a pivotal regulatory milestone as its Columbia Gold-Silver Project’s exploration amendment enters the public comment phase, paving the way for maiden drilling expected in April 2026.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Felix Gold has secured a bulk sampling permit to extract 1,600 tons of high-grade antimony ore from its Treasure Creek project in Alaska, marking a pivotal step towards near-term production. The permit supports multiple production pathways, including toll treatment in 2026 and a dedicated smelter by 2027.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.
Ada Torres
Ada Torres
23 Mar 2026
Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.
Ada Torres
Ada Torres
23 Mar 2026
St Barbara Limited is on track to complete key transactions with Lingbao Gold Group and Kumul Mineral Holdings, unlocking A$370 million in cash and advancing the New Simberi Gold Project.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.
Claire Turing
Claire Turing
20 Mar 2026
Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.
Ada Torres
Ada Torres
20 Mar 2026